ADAP - Adaptimmune Therapeutics' (ADAP) CEO Adrian Rawcliffe on Q1 2022 Results - Earnings Call Transcript
Adaptimmune Therapeutics plc (ADAP) Q1 2022 Earnings Conference Call May 09, 2022 8:00 AM ET Company Participants Juli Miller – Head-Investor Relations Adrian Rawcliffe – Chief Executive Officer Gavin Wood – Chief Financial Officer Helen Tayton-Martin – Chief Business Officer John Lunger – Chief Patient Supply Officer Elliot Norry – Chief Medical Officer Cintia Piccina – Chief Commercial Officer Conference Call Participants Marc Frahm – Cowen and Company Tony Butler – ROTH Capital Faisal Khurshid – SVB Securities Nick Abbott – Wells Fargo Mara Goldstein – Mizuho Presentation Operator Good morning and thank you for standing by. Welcome to the First Quarter 2022 Adaptimmune Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker
For further details see:
Adaptimmune Therapeutics' (ADAP) CEO Adrian Rawcliffe on Q1 2022 Results - Earnings Call Transcript